<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Creatine Loading Protocol: 20g/Day for 5-7 Days — What the...</title>
  <meta name="description" content="Evidence-based review of the creatine loading protocol. Covers the standard 20g/day for 5-7 days approach, muscle saturation data from biopsy studies, GI...">
  <meta name="robots" content="index, follow">
  <link rel="canonical" href="https://creatineresearch.co/dosing/creatine-loading-protocol">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://creatineresearch.co/dosing/creatine-loading-protocol">
  <meta property="og:title" content="Creatine Loading Protocol: 20g/Day for 5-7 Days — What the...">
  <meta property="og:description" content="Evidence-based review of the creatine loading protocol. Covers the standard 20g/day for 5-7 days approach, muscle saturation data from biopsy studies, GI...">
  <meta property="og:site_name" content="Creatine Research">
  <meta name="twitter:card" content="summary_large_image">
  <meta name="twitter:title" content="Creatine Loading Protocol: 20g/Day for 5-7 Days — What the...">
  <meta name="twitter:description" content="Evidence-based review of the creatine loading protocol. Covers the standard 20g/day for 5-7 days approach, muscle saturation data from biopsy studies, GI...">
  <script type="application/ld+json">
  {
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What is the recommended origins of the loading protocol?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The creatine loading protocol emerged from early investigations into phosphocreatine metabolism conducted at the Karolinska Institute in Stockholm. Harris et al. (1992) published the foundational study demonstrating that oral creatine monohydrate supplementation could significantly elevate intramuscular total creatine concentrations in human subjects. Their work in Clinical Science showed that ingesting 5 g of creatine monohydrate four to six times daily for two or more days increased total muscle creatine content by approximately 20%, with some subjects achieving increases of up to 30 mmol/kg dry weight."
      }
    },
    {
      "@type": "Question",
      "name": "What is the recommended standard protocol?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The conventional loading protocol involves consuming 20 g of creatine monohydrate daily, split into four equal doses of 5 g each, over a period of five to seven days. The rationale for dose fractionation is pharmacokinetic: a single 5 g dose produces a plasma creatine peak approximately 60-90 minutes after ingestion, and renal clearance begins to increase substantially as plasma levels rise. Splitting the dose maintains elevated plasma creatine for more hours of the day, maximizing the time window during which muscle uptake can occur."
      }
    },
    {
      "@type": "Question",
      "name": "What is the muscle biopsy evidence for saturation?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The gold standard for verifying creatine loading efficacy is muscle biopsy, typically obtained from the vastus lateralis. Hultman et al. (1996) obtained biopsies before and after the loading phase and documented total creatine increases averaging 20-25 mmol/kg dry weight. Importantly, they observed substantial inter-individual variation. Approximately 20-30% of subjects were classified as \"non-responders,\" showing increases of less than 10 mmol/kg dry weight. These individuals tended to have higher baseline creatine levels, suggesting their muscle stores were already near the physiological ceiling of approximately 155-160 mmol/kg dry weight."
      }
    },
    {
      "@type": "Question",
      "name": "What is the saturation timeline?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The temporal dynamics of muscle creatine accumulation during loading are well characterized. Approximately 30-40% of the total loading increment occurs in the first two days, with the majority of remaining uptake distributed across days three through five. By day five, plasma creatine levels during the post-dose window are largely excreted renally rather than taken up by muscle, indicating that the intracellular compartment is approaching capacity."
      }
    },
    {
      "@type": "Question",
      "name": "What is the gastrointestinal tolerance?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The most commonly reported side effect of the loading phase is gastrointestinal discomfort, including bloating, nausea, diarrhea, and stomach cramping. These symptoms are dose-dependent and related to the osmotic effects of unabsorbed creatine in the intestinal lumen. When 5 g of creatine monohydrate is dissolved in water, the resulting solution draws fluid into the gut via osmosis. Taking multiple large doses in a single day increases the likelihood of GI disturbance."
      }
    }
  ]
}
  </script>

  <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><rect fill='%230f172a' width='100' height='100' rx='12'/><text x='50' y='68' font-family='monospace' font-size='40' fill='%230284c7' text-anchor='middle'>Cr</text></svg>">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=DM+Sans:wght@400;500;600;700&family=Instrument+Serif:ital@0;1&display=swap" rel="stylesheet">
  <script src="https://cdn.tailwindcss.com"></script>
  <script>
    tailwind.config = {
      darkMode: 'class',
      theme: {
        extend: {
          fontFamily: {
            sans: ['DM Sans', 'system-ui', 'sans-serif'],
            serif: ['Instrument Serif', 'Georgia', 'serif'],
          },
          colors: {
            slate: { 925: '#0c0f14', 950: '#090b10' }
          }
        }
      }
    }
  </script>
  <style>
    ::selection { background: rgba(2, 132, 199, 0.3); }
    ::-webkit-scrollbar { width: 8px; }
    ::-webkit-scrollbar-track { background: var(--bg-secondary, #18181b); }
    ::-webkit-scrollbar-thumb { background: var(--border, #27272a); border-radius: 4px; }
    ::-webkit-scrollbar-thumb:hover { background: #3f3f46; }

    /* Article body — light mode */
    .article-body { max-width: 720px; margin: 0 auto; padding: 0 1rem; }
    .article-body h1 { font-family: 'Instrument Serif', Georgia, serif; font-size: 2.75rem; line-height: 1.15; margin-bottom: 1rem; color: #0f172a; }
    .article-body h2 { font-family: 'Instrument Serif', Georgia, serif; font-size: 1.875rem; margin: 2.5rem 0 1rem; color: #0f172a; }
    .article-body h3 { font-size: 1.25rem; font-weight: 600; margin: 2rem 0 0.75rem; color: #0f172a; }
    .article-body p { margin-bottom: 1.5rem; color: #475569; line-height: 1.8; }
    .article-body a { color: #0284c7; text-decoration: none; }
    .article-body a:hover { text-decoration: underline; }
    .article-body ul, .article-body ol { margin: 1.5rem 0; padding-left: 1.5rem; color: #475569; }
    .article-body li { margin-bottom: 0.75rem; line-height: 1.7; }
    .article-body strong { color: #1e293b; }
    .article-body blockquote { border-left: 3px solid #0284c7; padding-left: 1.5rem; margin: 2rem 0; font-style: italic; color: #334155; }
    .article-body .meta { color: #64748b; font-size: 0.9rem; margin-bottom: 2rem; }
    .article-body table { width: 100%; border-collapse: collapse; margin: 2rem 0; }
    .article-body th, .article-body td { text-align: left; padding: 0.75rem 1rem; border-bottom: 1px solid #e2e8f0; color: #475569; }
    .article-body th { color: #0f172a; font-weight: 600; border-bottom: 2px solid #cbd5e1; }
    .article-body .cta-box {
      background: linear-gradient(135deg, rgba(2, 132, 199, 0.08), rgba(13, 148, 136, 0.04));
      border: 1px solid rgba(2, 132, 199, 0.2);
      border-radius: 16px; padding: 2.5rem; margin: 3rem 0; text-align: center;
    }
    .article-body .cta-box h3 { margin-top: 0; font-family: 'Instrument Serif', Georgia, serif; font-size: 1.5rem; }
    .article-body .cta-box p { color: #64748b; margin-bottom: 1.5rem; }
    .article-body .cta-button {
      display: inline-block; background: #0284c7; color: #ffffff;
      padding: 1rem 2rem; border-radius: 8px; font-weight: 600;
      text-decoration: none; transition: background 0.2s;
    }
    .article-body .cta-button:hover { background: #0ea5e9; text-decoration: none; }
    .article-body .related-articles { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .related-articles h3 { margin-bottom: 1rem; }
    .article-body .related-articles ul { list-style: none; padding: 0; }
    .article-body .related-articles li { margin-bottom: 0.5rem; }
    .article-body .faq-section { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .faq-section > h2 { margin-top: 0; }
    .article-body .faq-item { margin-bottom: 2rem; }
    .article-body .faq-item h3 { color: #0f172a; margin-bottom: 0.5rem; }
    .article-body .faq-item p { margin-bottom: 0; }

    /* Article body — dark mode */
    .dark .article-body h1, .dark .article-body h2, .dark .article-body h3 { color: #fafaf9; }
    .dark .article-body p { color: #a1a1aa; }
    .dark .article-body ul, .dark .article-body ol { color: #a1a1aa; }
    .dark .article-body strong { color: #e4e4e7; }
    .dark .article-body a { color: #38bdf8; }
    .dark .article-body blockquote { color: #d4d4d8; }
    .dark .article-body .meta { color: #71717a; }
    .dark .article-body th, .dark .article-body td { border-bottom-color: #27272a; color: #a1a1aa; }
    .dark .article-body th { color: #fafaf9; border-bottom-color: #3f3f46; }
    .dark .article-body .cta-box { background: linear-gradient(135deg, rgba(2, 132, 199, 0.12), rgba(13, 148, 136, 0.06)); }
    .dark .article-body .cta-box p { color: #a1a1aa; }
    .dark .article-body .related-articles { border-top-color: #27272a; }
    .dark .article-body .faq-section { border-top-color: #27272a; }
    .dark .article-body .faq-item h3 { color: #fafaf9; }

    /* Newsletter section */
    #newsletter input::placeholder { color: #94a3b8; }
    .dark #newsletter input::placeholder { color: #52525b; }


    /* Mega menu */
    .mega-panel { transition: opacity 0.15s ease, visibility 0.15s ease; }
    .mega-panel.hidden { opacity: 0; visibility: hidden; display: none; }
    .mega-panel:not(.hidden) { opacity: 1; visibility: visible; display: block; }
    .mega-link {
      display: block; padding: 6px 0;
      font-size: 0.875rem; color: #475569;
      transition: color 0.15s;
    }
    .mega-link:hover { color: #0f172a; text-decoration: none; }
    .dark .mega-link { color: #a1a1aa; }
    .dark .mega-link:hover { color: #fafaf9; }
    .mega-view-all {
      display: inline-block; margin-top: 12px;
      font-size: 0.8125rem; font-weight: 500;
      color: #0284c7; transition: color 0.15s;
    }
    .mega-view-all:hover { color: #0ea5e9; text-decoration: none; }
    .dark .mega-view-all { color: #38bdf8; }
    .dark .mega-view-all:hover { color: #7dd3fc; }

    /* Nav effects */
    .nav-link { position: relative; }
    .nav-link::after {
      content: ''; position: absolute; bottom: -2px; left: 0;
      width: 0; height: 1px; background: #0284c7; transition: width 0.3s ease;
    }
    .nav-link:hover::after { width: 100%; }
    .cta-glow { position: relative; }
    .cta-glow::before {
      content: ''; position: absolute; inset: -2px;
      background: linear-gradient(135deg, #0284c7, #0891b2);
      border-radius: inherit; opacity: 0; filter: blur(12px);
      transition: opacity 0.3s ease; z-index: -1;
    }
    .cta-glow:hover::before { opacity: 0.4; }

    /* Active trigger state */
    .mega-trigger[aria-expanded="true"] { color: #0f172a; }
    .dark .mega-trigger[aria-expanded="true"] { color: #fafaf9; }
    .mega-trigger[aria-expanded="true"] svg { transform: rotate(180deg); }


    @media (max-width: 768px) {
      .article-body h1 { font-size: 2rem; }
      .article-body h2 { font-size: 1.5rem; }
    }
  </style>
</head>
<body class="bg-slate-50 dark:bg-slate-950 font-sans antialiased">

  <nav class="fixed top-0 left-0 right-0 z-50 border-b border-slate-200 dark:border-zinc-800/60 bg-white/90 dark:bg-slate-950/90 backdrop-blur-md">
    <div class="max-w-7xl mx-auto">
      <div class="flex items-center justify-between h-16 px-6">
        <!-- Logo -->
        <a href="/" class="flex items-center gap-3 group">
          <div class="w-8 h-8 rounded-md bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center group-hover:border-sky-500/50 transition-colors">
            <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
          </div>
          <span class="text-slate-500 dark:text-zinc-400 text-sm tracking-tight">
            <span class="text-slate-800 dark:text-zinc-200 font-medium">Creatine</span><span class="text-sky-600 dark:text-sky-400">Research</span>
          </span>
        </a>

        <!-- Desktop Nav -->
        <div class="hidden lg:flex items-center gap-1">

          <!-- Science dropdown -->
          <div class="relative" data-mega="science">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Research
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- Applications dropdown -->
          <div class="relative" data-mega="applications">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Applications
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- All Articles link -->
          <a href="/articles" class="nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors">All Articles</a>

          <div class="w-px h-4 bg-slate-300 dark:bg-zinc-800 mx-2"></div>

          <!-- CTA -->
          <a href="#newsletter" class="px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors cta-glow">Research Updates</a>
        </div>

        <!-- Mobile menu button -->
        <button id="mobile-menu-btn" class="lg:hidden p-2 text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200">
          <svg id="menu-icon" class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
          <svg id="close-icon" class="w-5 h-5 hidden" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"></path></svg>
        </button>
      </div>

      <!-- ═══ MEGA PANEL: Research ═══ -->
      <div id="mega-science" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-3 gap-8">
            <!-- Column 1: Science -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Science & Mechanisms</span>
              </div>
              <div class="space-y-1">
                <a href="/science/what-is-creatine-monohydrate" class="mega-link">What Is Creatine Monohydrate?</a>
                <a href="/science/how-creatine-works-in-the-body" class="mega-link">How Creatine Works</a>
                <a href="/science/creatine-atp-resynthesis" class="mega-link">ATP Resynthesis</a>
                <a href="/science/creatine-and-muscle-growth" class="mega-link">Muscle Growth Research</a>
                <a href="/science/creatine-and-brain-function" class="mega-link">Brain Function</a>
                <a href="/science/creatine-and-aging" class="mega-link">Aging & Sarcopenia</a>
              </div>
              <a href="/science" class="mega-view-all">All 20 articles &rarr;</a>
            </div>

            <!-- Column 2: Dosing & Safety -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-teal-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12h6m-6 4h6m2 5H7a2 2 0 01-2-2V5a2 2 0 012-2h5.586a1 1 0 01.707.293l5.414 5.414a1 1 0 01.293.707V19a2 2 0 01-2 2z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Dosing & Safety</span>
              </div>
              <div class="space-y-1">
                <a href="/dosing/creatine-loading-protocol" class="mega-link">Loading Protocol</a>
                <a href="/dosing/creatine-maintenance-dose" class="mega-link">Maintenance Dosing</a>
                <a href="/dosing/creatine-timing-before-or-after-workout" class="mega-link">Timing: Before or After?</a>
                <a href="/safety/is-creatine-safe" class="mega-link">Is Creatine Safe?</a>
                <a href="/safety/creatine-and-kidneys" class="mega-link">Kidney Health</a>
                <a href="/safety/creatine-and-hair-loss" class="mega-link">Hair Loss Myth</a>
              </div>
              <a href="/dosing" class="mega-view-all">Dosing (15) &rarr;</a>
              <span class="mx-2 text-slate-300 dark:text-zinc-700">|</span>
              <a href="/safety" class="mega-view-all">Safety (15) &rarr;</a>
            </div>

            <!-- Column 3: CTA Card -->
            <div class="bg-gradient-to-br from-sky-500/10 to-teal-500/5 dark:from-sky-500/15 dark:to-teal-500/5 border border-sky-500/20 rounded-xl p-6 flex flex-col justify-between">
              <div>
                <h3 class="text-lg font-semibold text-slate-900 dark:text-zinc-100 mb-2">Evidence-Based Research</h3>
                <p class="text-sm text-slate-600 dark:text-zinc-400 mb-4">Every article cites peer-reviewed studies. No marketing hype. Just what the science shows.</p>
              </div>
              <a href="/science/creatine-mechanisms-summary" class="inline-flex items-center justify-center px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg text-sm transition-colors cta-glow">
                Complete Research Guide
              </a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ MEGA PANEL: Applications ═══ -->
      <div id="mega-applications" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-4 gap-8">
            <!-- Column 1: By Sport -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-amber-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 10V3L4 14h7v7l9-11h-7z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">By Sport</span>
              </div>
              <div class="space-y-1">
                <a href="/sports/creatine-for-powerlifting" class="mega-link">Powerlifting</a>
                <a href="/sports/creatine-for-bodybuilding" class="mega-link">Bodybuilding</a>
                <a href="/sports/creatine-for-crossfit" class="mega-link">CrossFit</a>
                <a href="/sports/creatine-for-mma" class="mega-link">MMA & Combat Sports</a>
                <a href="/sports/creatine-for-soccer" class="mega-link">Soccer</a>
                <a href="/sports/creatine-for-swimming" class="mega-link">Swimming</a>
              </div>
              <a href="/sports" class="mega-view-all">All 20 sports &rarr;</a>
            </div>

            <!-- Column 2: Comparisons -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-violet-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M8 7h12m0 0l-4-4m4 4l-4 4m0 6H4m0 0l4 4m-4-4l4-4"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">vs Other Supplements</span>
              </div>
              <div class="space-y-1">
                <a href="/comparisons/creatine-vs-protein-powder" class="mega-link">vs Protein Powder</a>
                <a href="/comparisons/creatine-vs-bcaa" class="mega-link">vs BCAAs</a>
                <a href="/comparisons/creatine-vs-beta-alanine" class="mega-link">vs Beta-Alanine</a>
                <a href="/comparisons/creatine-vs-pre-workout" class="mega-link">vs Pre-Workout</a>
                <a href="/comparisons/creatine-vs-ashwagandha" class="mega-link">vs Ashwagandha</a>
              </div>
              <a href="/comparisons" class="mega-view-all">All 15 comparisons &rarr;</a>
            </div>

            <!-- Column 3: Product Quality -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-emerald-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5.618-4.016A11.955 11.955 0 0112 2.944a11.955 11.955 0 01-8.618 3.04A12.02 12.02 0 003 9c0 5.591 3.824 10.29 9 11.622 5.176-1.332 9-6.03 9-11.622 0-1.042-.133-2.052-.382-3.016z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Product Quality</span>
              </div>
              <div class="space-y-1">
                <a href="/quality/creatine-monohydrate-vs-hcl" class="mega-link">Monohydrate vs HCl</a>
                <a href="/quality/creatine-forms-comparison" class="mega-link">All Forms Compared</a>
                <a href="/quality/third-party-testing-creatine" class="mega-link">Third-Party Testing</a>
                <a href="/quality/creapure-vs-generic-creatine" class="mega-link">Creapure vs Generic</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/quality" class="mega-view-all">All 15 guides &rarr;</a>
            </div>

            <!-- Column 4: Quick Links -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 7h8m0 0v8m0-8l-8 8-4-4-6 6"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Quick Links</span>
              </div>
              <div class="space-y-1">
                <a href="/science/creatine-mechanisms-summary" class="mega-link">Complete Science Guide</a>
                <a href="/dosing/creatine-dosing-protocols-summary" class="mega-link">Complete Dosing Guide</a>
                <a href="/safety/creatine-safety-complete-guide" class="mega-link">Complete Safety Guide</a>
                <a href="/sports/creatine-for-sport-summary" class="mega-link">Every Sport Guide</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/articles" class="mega-view-all">All 100 articles &rarr;</a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ Mobile Menu ═══ -->
      <div id="mobile-menu" class="hidden lg:hidden border-t border-slate-200 dark:border-zinc-800 bg-white dark:bg-slate-950 max-h-[80vh] overflow-y-auto">
        <div class="px-6 py-4 space-y-1">
          <!-- Research -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Research
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Science</p>
            <a href="/science/what-is-creatine-monohydrate" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">What Is Creatine?</a>
            <a href="/science/how-creatine-works-in-the-body" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">How Creatine Works</a>
            <a href="/science" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Dosing</p>
            <a href="/dosing/creatine-loading-protocol" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Loading Protocol</a>
            <a href="/dosing/creatine-maintenance-dose" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Maintenance Dose</a>
            <a href="/dosing" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Safety</p>
            <a href="/safety/is-creatine-safe" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Is Creatine Safe?</a>
            <a href="/safety/creatine-and-kidneys" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Kidney Health</a>
            <a href="/safety" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
          </div>

          <!-- Applications -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Applications
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Sports</p>
            <a href="/sports/creatine-for-powerlifting" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Powerlifting</a>
            <a href="/sports/creatine-for-bodybuilding" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Bodybuilding</a>
            <a href="/sports" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 sports &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Comparisons</p>
            <a href="/comparisons/creatine-vs-protein-powder" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs Protein Powder</a>
            <a href="/comparisons/creatine-vs-bcaa" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs BCAAs</a>
            <a href="/comparisons" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 comparisons &rarr;</a>
          </div>

          <!-- Direct links -->
          <a href="/articles" class="block py-3 text-slate-800 dark:text-zinc-200 font-medium">All Articles</a>

          <!-- CTA -->
          <a href="#newsletter" class="block mt-4 py-3 bg-sky-600 text-white text-center font-semibold rounded-lg">Get Research Updates</a>
        </div>
      </div>
    </div>
  </nav>

  <main class="pt-24 pb-16">
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mb-6">
      <div class="flex items-center gap-2 text-sm">
        <a href="/" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Home</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/articles" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Articles</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/dosing" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Dosing Protocols</a>
      </div>
    </div>
    <div class="article-body">
      <article>
    <header>
      <nav aria-label="Breadcrumb">
        <ol>
          <li><a href="/">Home</a></li>
          <li><a href="/dosing">Dosing Protocols</a></li>
          <li aria-current="page">Creatine Loading Protocol</li>
        </ol>
      </nav>
      <h1>Creatine Loading Protocol: 20g/Day for 5-7 Days — What the Research Says</h1>
      <p>The loading protocol is the most studied method for rapidly saturating intramuscular creatine stores. This article examines the original research, practical implementation, tolerability, and whether loading is necessary for all users.</p>
      <time datetime="2026-01-28">January 28, 2026</time>
    </header>

    <section>
      <h2>Origins of the Loading Protocol</h2>
      <p>The creatine loading protocol emerged from early investigations into phosphocreatine metabolism conducted at the Karolinska Institute in Stockholm. Harris et al. (1992) published the foundational study demonstrating that oral creatine monohydrate supplementation could significantly elevate intramuscular total creatine concentrations in human subjects. Their work in Clinical Science showed that ingesting 5 g of creatine monohydrate four to six times daily for two or more days increased total muscle creatine content by approximately 20%, with some subjects achieving increases of up to 30 mmol/kg dry weight.</p>
      <p>This finding was remarkable because it demonstrated a dietary intervention capable of meaningfully altering skeletal muscle biochemistry within days rather than weeks. Prior to this work, phosphocreatine levels were considered relatively stable properties of muscle tissue, modifiable only through chronic training adaptations. Harris and colleagues showed that the creatine transporter system was not fully saturated under normal dietary conditions, leaving room for exogenous supplementation to increase intracellular stores.</p>
      <p>Building on the Harris data, Hultman et al. (1996) systematically characterized the loading and maintenance phases in a study published in the Journal of Applied Physiology. They confirmed that 20 g/day (divided into four equal 5 g doses) for five to six days reliably elevated muscle total creatine from a baseline of approximately 120 mmol/kg dry weight to approximately 140-155 mmol/kg dry weight. Subjects with lower initial creatine concentrations (such as vegetarians) showed the greatest absolute increases, while those with already-elevated baseline levels experienced more modest gains.</p>
    </section>

    <section>
      <h2>The Standard Protocol: 4 x 5 g Per Day</h2>
      <p>The conventional loading protocol involves consuming 20 g of creatine monohydrate daily, split into four equal doses of 5 g each, over a period of five to seven days. The rationale for dose fractionation is pharmacokinetic: a single 5 g dose produces a plasma creatine peak approximately 60-90 minutes after ingestion, and renal clearance begins to increase substantially as plasma levels rise. Splitting the dose maintains elevated plasma creatine for more hours of the day, maximizing the time window during which muscle uptake can occur.</p>
      <p>Muscle creatine uptake follows saturation kinetics. The sodium- and chloride-dependent creatine transporter (CRT, encoded by the SLC6A8 gene) has a finite transport capacity. During loading, uptake is highest in the first two days when the gradient between plasma and intracellular creatine is greatest. By days four and five, uptake rates decline as intramuscular stores approach their ceiling. Most individuals achieve near-maximal saturation within five days. Extending loading to seven days provides a small additional increment for non-responders or individuals with higher muscle mass.</p>
      <p>The total creatine pool in a 70 kg individual is approximately 120-140 g, with roughly 95% residing in skeletal muscle. Daily turnover (degradation of creatine and phosphocreatine to creatinine) amounts to approximately 1.7-2.0% of the total pool, or roughly 2 g per day. Loading rapidly fills the pool beyond what diet alone (typically contributing 1-2 g/day from meat and fish) and endogenous synthesis (approximately 1 g/day from the liver and kidneys) can maintain.</p>
    </section>

    <section>
      <h2>Muscle Biopsy Evidence for Saturation</h2>
      <p>The gold standard for verifying creatine loading efficacy is muscle biopsy, typically obtained from the vastus lateralis. Hultman et al. (1996) obtained biopsies before and after the loading phase and documented total creatine increases averaging 20-25 mmol/kg dry weight. Importantly, they observed substantial inter-individual variation. Approximately 20-30% of subjects were classified as "non-responders," showing increases of less than 10 mmol/kg dry weight. These individuals tended to have higher baseline creatine levels, suggesting their muscle stores were already near the physiological ceiling of approximately 155-160 mmol/kg dry weight.</p>
      <p>The proportion of the elevated creatine that exists as phosphocreatine (PCr) versus free creatine (Cr) is physiologically relevant. After loading, both fractions increase, but the PCr/Cr ratio tends to shift modestly toward free creatine in resting muscle. During exercise, the expanded PCr pool enables greater ATP resynthesis during high-intensity efforts, which is the primary ergogenic mechanism.</p>
      <p>Casey et al. (1996) corroborated these findings using phosphorus-31 magnetic resonance spectroscopy (31P-MRS) as a non-invasive alternative to biopsy. Their data confirmed that muscle PCr concentrations increased significantly after five days of loading at 20 g/day, and that this increase correlated with improved performance in repeated maximal voluntary contractions. The 31P-MRS approach also demonstrated faster PCr resynthesis between bouts of exercise, indicating enhanced recovery capacity at the metabolic level.</p>
    </section>

    <section>
      <h2>Saturation Timeline</h2>
      <p>The temporal dynamics of muscle creatine accumulation during loading are well characterized. Approximately 30-40% of the total loading increment occurs in the first two days, with the majority of remaining uptake distributed across days three through five. By day five, plasma creatine levels during the post-dose window are largely excreted renally rather than taken up by muscle, indicating that the intracellular compartment is approaching capacity.</p>
      <p>Urinary creatine excretion provides an indirect marker of loading completeness. During the first two days of loading, urinary creatine excretion is relatively low (indicating efficient muscle uptake). By days four and five, urinary excretion increases substantially, sometimes reaching 40-60% of the ingested dose. This shift from retention to excretion signals that the muscle compartment is nearing saturation and additional loading provides diminishing returns.</p>
      <p>After loading, the transition to a maintenance dose of 3-5 g/day is sufficient to sustain elevated stores. Hultman et al. (1996) showed that without maintenance dosing, creatine levels returned to baseline over approximately 28-30 days, consistent with the known daily turnover rate of approximately 2 g/day and the roughly 20-40 g of additional creatine stored during loading.</p>
    </section>

    <section>
      <h2>Gastrointestinal Tolerance</h2>
      <p>The most commonly reported side effect of the loading phase is gastrointestinal discomfort, including bloating, nausea, diarrhea, and stomach cramping. These symptoms are dose-dependent and related to the osmotic effects of unabsorbed creatine in the intestinal lumen. When 5 g of creatine monohydrate is dissolved in water, the resulting solution draws fluid into the gut via osmosis. Taking multiple large doses in a single day increases the likelihood of GI disturbance.</p>
      <p>Ostojic and Ahmetovic (2008) reported that dividing the 20 g daily dose into smaller portions (e.g., four doses of 5 g or even ten doses of 2 g) reduced GI symptoms without compromising total muscle uptake. The practical recommendation from the literature is to consume each 5 g dose with at least 250-300 mL of water, taken with meals when possible, and to space doses at least three to four hours apart.</p>
      <p>It is worth noting that GI symptoms during loading are generally mild, self-limiting, and affect a minority of users. In large-scale reviews of creatine supplementation trials, including the comprehensive 2017 position stand by the International Society of Sports Nutrition, the incidence of clinically significant GI side effects during loading is low when dosing guidelines are followed.</p>
    </section>

    <section>
      <h2>Who Benefits from Loading</h2>
      <p>Loading is most advantageous when rapid saturation is desired. Athletes facing an imminent competition, individuals beginning a peaking block in training, or anyone who wants to begin experiencing the ergogenic effects of creatine within the first week of supplementation may prefer the loading approach. The alternative, taking 3-5 g/day without loading, achieves the same saturation endpoint but requires approximately 28 days (as demonstrated by Hultman et al., 1996).</p>
      <p>Vegetarians and vegans tend to have lower baseline intramuscular creatine due to the absence of dietary creatine from meat and fish. This population generally shows the most pronounced response to loading, with larger absolute increases in muscle creatine and often more noticeable performance improvements. Burke et al. (2003) specifically examined vegetarians and found significantly greater lean mass and muscular performance gains compared to omnivores following the same loading protocol.</p>
      <p>Conversely, loading is not strictly necessary. As detailed in the companion article on skipping the loading phase, daily low-dose supplementation achieves equivalent saturation given sufficient time. The choice between loading and gradual accumulation is ultimately one of convenience and tolerance rather than of efficacy at steady state.</p>
    </section>

    <section>
      <h2>Who Might Skip Loading</h2>
      <p>Individuals with sensitive gastrointestinal systems, those who dislike taking large doses of any supplement, and anyone without time-sensitive performance goals can reasonably opt out of loading. The endpoint is the same: saturated muscle creatine stores maintained by a daily dose of 3-5 g. The only difference is the time required to reach that endpoint.</p>
      <p>Additionally, individuals who are already consuming substantial dietary creatine (e.g., those eating over 1 kg of red meat per day, which would provide approximately 4-5 g of creatine) may have partially elevated baseline stores, reducing the relative benefit of a rapid loading phase. For these individuals, a maintenance dose alone may be sufficient from the outset, though this scenario is uncommon in practice.</p>
    </section>

    <section>
      <h2>Practical Recommendations</h2>
      <p>Based on the totality of published evidence, the following protocol represents the standard loading approach:</p>
      <ol>
        <li>Consume 5 g of creatine monohydrate four times per day (total: 20 g/day) for five to seven days.</li>
        <li>Dissolve each dose in at least 250-300 mL of water or other fluid.</li>
        <li>Space doses at least three to four hours apart (e.g., breakfast, lunch, afternoon, dinner).</li>
        <li>Taking doses with meals may improve GI tolerance and, per Green et al. (1996), the insulin response from carbohydrate-containing meals may modestly enhance muscle creatine uptake.</li>
        <li>After five to seven days, transition to a maintenance dose of 3-5 g/day.</li>
      </ol>
      <p>There is no evidence supporting doses higher than 20 g/day for loading. Excess creatine beyond what the transporter system can handle is simply excreted in the urine, providing no additional benefit while increasing cost and GI burden.</p>
    </section>

    <section>
      <h2>Summary</h2>
      <p>The loading protocol is a well-validated method for rapidly elevating intramuscular creatine stores to near their physiological maximum. Five days of 20 g/day (4 x 5 g) produces consistent increases of 20-25 mmol/kg dry weight in most individuals, as confirmed by muscle biopsy and MRS data. GI side effects are manageable with proper dose fractionation. Loading is most appropriate when rapid saturation is desired, particularly for vegetarians and athletes with near-term competitive demands. The alternative of chronic low-dose supplementation (3-5 g/day) reaches the same saturation point in approximately four weeks.</p>
    </section>

    <section>
      <h2>Bibliography</h2>
      <ol>
        <li>Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. <em>Clinical Science</em>. 1992;83(3):367-374. doi:10.1042/cs0830367. PMID: 1327657.</li>
        <li>Hultman E, Soderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. <em>Journal of Applied Physiology</em>. 1996;81(1):232-237. doi:10.1152/jappl.1996.81.1.232. PMID: 8828669.</li>
        <li>Casey A, Constantin-Teodosiu D, Howell S, Hultman E, Greenhaff PL. Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans. <em>American Journal of Physiology</em>. 1996;271(1 Pt 1):E31-37. doi:10.1152/ajpendo.1996.271.1.E31. PMID: 8760078.</li>
        <li>Green AL, Hultman E, Macdonald IA, Sewell DA, Greenhaff PL. Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. <em>American Journal of Physiology</em>. 1996;271(5 Pt 1):E821-826. doi:10.1152/ajpendo.1996.271.5.E821. PMID: 8944667.</li>
        <li>Burke DG, Chilibeck PD, Parise G, Candow DG, Mahoney D, Tarnopolsky M. Effect of creatine and weight training on muscle creatine and performance in vegetarians. <em>Medicine and Science in Sports and Exercise</em>. 2003;35(11):1946-1955. doi:10.1249/01.MSS.0000093614.17517.79. PMID: 14600563.</li>
        <li>Ostojic SM, Ahmetovic Z. Gastrointestinal distress after creatine supplementation in athletes: are side effects dose dependent? <em>Research in Sports Medicine</em>. 2008;16(1):15-22. doi:10.1080/15438620701693280. PMID: 18373285.</li>
        <li>Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. <em>Journal of the International Society of Sports Nutrition</em>. 2017;14:18. doi:10.1186/s12970-017-0173-z. PMID: 28615996.</li>
      </ol>
    </section>
      
      <section class="faq-section">
        <h2>Frequently Asked Questions</h2>
        
        <div class="faq-item">
          <h3>What is the recommended origins of the loading protocol?</h3>
          <p>The creatine loading protocol emerged from early investigations into phosphocreatine metabolism conducted at the Karolinska Institute in Stockholm. Harris et al. (1992) published the foundational study demonstrating that oral creatine monohydrate supplementation could significantly elevate intramuscular total creatine concentrations in human subjects. Their work in Clinical Science showed that ingesting 5 g of creatine monohydrate four to six times daily for two or more days increased total muscle creatine content by approximately 20%, with some subjects achieving increases of up to 30 mmol/kg dry weight.</p>
        </div>
        <div class="faq-item">
          <h3>What is the recommended standard protocol?</h3>
          <p>The conventional loading protocol involves consuming 20 g of creatine monohydrate daily, split into four equal doses of 5 g each, over a period of five to seven days. The rationale for dose fractionation is pharmacokinetic: a single 5 g dose produces a plasma creatine peak approximately 60-90 minutes after ingestion, and renal clearance begins to increase substantially as plasma levels rise. Splitting the dose maintains elevated plasma creatine for more hours of the day, maximizing the time window during which muscle uptake can occur.</p>
        </div>
        <div class="faq-item">
          <h3>What is the muscle biopsy evidence for saturation?</h3>
          <p>The gold standard for verifying creatine loading efficacy is muscle biopsy, typically obtained from the vastus lateralis. Hultman et al. (1996) obtained biopsies before and after the loading phase and documented total creatine increases averaging 20-25 mmol/kg dry weight. Importantly, they observed substantial inter-individual variation. Approximately 20-30% of subjects were classified as "non-responders," showing increases of less than 10 mmol/kg dry weight. These individuals tended to have higher baseline creatine levels, suggesting their muscle stores were already near the physiological ceiling of approximately 155-160 mmol/kg dry weight.</p>
        </div>
        <div class="faq-item">
          <h3>What is the saturation timeline?</h3>
          <p>The temporal dynamics of muscle creatine accumulation during loading are well characterized. Approximately 30-40% of the total loading increment occurs in the first two days, with the majority of remaining uptake distributed across days three through five. By day five, plasma creatine levels during the post-dose window are largely excreted renally rather than taken up by muscle, indicating that the intracellular compartment is approaching capacity.</p>
        </div>
        <div class="faq-item">
          <h3>What is the gastrointestinal tolerance?</h3>
          <p>The most commonly reported side effect of the loading phase is gastrointestinal discomfort, including bloating, nausea, diarrhea, and stomach cramping. These symptoms are dose-dependent and related to the osmotic effects of unabsorbed creatine in the intestinal lumen. When 5 g of creatine monohydrate is dissolved in water, the resulting solution draws fluid into the gut via osmosis. Taking multiple large doses in a single day increases the likelihood of GI disturbance.</p>
        </div>
      </section>
      
      </article>

      <!-- In-article CTA -->
      <div class="cta-box">
        <h3>Stay Current on Creatine Research</h3>
        <p>Get evidence-based updates when new studies are published. No hype, no marketing — just what the science shows.</p>
        <a href="#newsletter" class="cta-button">Get Research Updates</a>
      </div>

      <!-- Pillar page link -->
      <div class="related-articles">
        <h3>Read the Full Guide</h3>
        <p style="margin-bottom: 0.75rem;"><a href="/dosing/creatine-dosing-protocols-summary">Complete Dosing Guide: Dosing Protocols</a> — comprehensive overview with all cited sources.</p>
      </div>
    </div>

    <!-- Category nav -->
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mt-12">
      <div class="flex items-center justify-between p-5 bg-slate-100 dark:bg-zinc-900/50 border border-slate-200 dark:border-zinc-800/60 rounded-xl">
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-1">Category</p>
          <a href="/dosing" class="text-slate-800 dark:text-zinc-200 font-medium hover:text-sky-600 dark:hover:text-sky-400 transition-colors">Dosing Protocols</a>
        </div>
        <a href="/dosing" class="text-sm text-sky-600 dark:text-sky-400 font-medium hover:underline">Browse all &rarr;</a>
      </div>
    </div>
  </main>

  <!-- Newsletter section -->
  <section id="newsletter" class="py-16 bg-slate-100 dark:bg-zinc-900/30 border-t border-slate-200 dark:border-zinc-800/60">
    <div class="max-w-xl mx-auto px-6 text-center">
      <h2 class="font-serif text-3xl text-slate-900 dark:text-zinc-100 mb-3">Research Updates</h2>
      <p class="text-slate-600 dark:text-zinc-400 mb-6">New studies, mechanism breakdowns, and dosing insights — delivered when they matter. No spam. Unsubscribe anytime.</p>
      <form class="flex flex-col sm:flex-row gap-3 justify-center" onsubmit="return false;">
        <input type="email" placeholder="your@email.com" class="px-4 py-3 rounded-lg border border-slate-300 dark:border-zinc-700 bg-white dark:bg-zinc-800 text-slate-900 dark:text-zinc-100 focus:outline-none focus:ring-2 focus:ring-sky-500 w-full sm:w-72">
        <button type="submit" class="px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg transition-colors cta-glow">Subscribe</button>
      </form>
      <p class="text-xs text-slate-500 dark:text-zinc-600 mt-3">100% evidence-based. Every claim cited.</p>
    </div>
  </section>


  <footer class="py-16 border-t border-slate-200 dark:border-zinc-900">
    <div class="max-w-7xl mx-auto px-6">
      <div class="grid grid-cols-2 md:grid-cols-6 gap-8 mb-12">
        <div class="col-span-2 md:col-span-2">
          <div class="flex items-center gap-3 mb-3">
            <div class="w-8 h-8 rounded bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center">
              <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
            </div>
            <span class="text-slate-700 dark:text-zinc-300 font-medium">Creatine Research</span>
          </div>
          <p class="text-sm text-slate-600 dark:text-zinc-500 mb-6 max-w-xs">Evidence-based creatine research. Every claim cited. No marketing hype.</p>
          <a href="#newsletter" class="inline-block px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors">Research Updates</a>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Research</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science</a></li>
            <li><a href="/dosing" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing</a></li>
            <li><a href="/safety" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Applications</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/sports" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">By Sport</a></li>
            <li><a href="/comparisons" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Comparisons</a></li>
            <li><a href="/quality" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Product Quality</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Guides</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science/creatine-mechanisms-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science Guide</a></li>
            <li><a href="/dosing/creatine-dosing-protocols-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing Guide</a></li>
            <li><a href="/safety/creatine-safety-complete-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety Guide</a></li>
            <li><a href="/quality/creatine-buying-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Buying Guide</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Site</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Home</a></li>
            <li><a href="/articles" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">All Articles</a></li>
            <li><a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Scale With Search</a></li>
          </ul>
        </div>
      </div>
      <div class="pt-8 border-t border-slate-200 dark:border-zinc-900 flex flex-col md:flex-row items-center justify-between gap-4">
        <p class="text-xs text-slate-500 dark:text-zinc-700">&copy; 2026 Creatine Research. All cited sources are property of their respective authors.</p>
        <p class="text-xs text-slate-500 dark:text-zinc-700">Powered by <a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-sky-500">Scale With Search</a></p>
      </div>
    </div>
  </footer>


  <script>
    // Theme
    if (localStorage.theme === 'light') {
      document.documentElement.classList.remove('dark');
    } else if (localStorage.theme === 'dark' || !('theme' in localStorage)) {
      document.documentElement.classList.add('dark');
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
      document.documentElement.classList.add('dark');
    }

    // Mega menu
    (function() {
      const triggers = document.querySelectorAll('.mega-trigger');
      const panels = document.querySelectorAll('.mega-panel');
      let activePanel = null;
      let closeTimeout = null;

      function openPanel(id) {
        clearTimeout(closeTimeout);
        panels.forEach(p => { p.classList.add('hidden'); });
        triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        const panel = document.getElementById('mega-' + id);
        const trigger = document.querySelector('[data-mega="' + id + '"] .mega-trigger');
        if (panel) { panel.classList.remove('hidden'); activePanel = panel; }
        if (trigger) trigger.setAttribute('aria-expanded', 'true');
      }

      function scheduleClose() {
        closeTimeout = setTimeout(() => {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
          activePanel = null;
        }, 200);
      }

      function cancelClose() { clearTimeout(closeTimeout); }

      triggers.forEach(btn => {
        const wrapper = btn.closest('[data-mega]');
        const id = wrapper.getAttribute('data-mega');
        btn.addEventListener('mouseenter', () => openPanel(id));
        btn.addEventListener('click', (e) => {
          e.preventDefault();
          const panel = document.getElementById('mega-' + id);
          if (panel && !panel.classList.contains('hidden')) {
            panel.classList.add('hidden');
            btn.setAttribute('aria-expanded', 'false');
          } else {
            openPanel(id);
          }
        });
        wrapper.addEventListener('mouseleave', scheduleClose);
      });

      panels.forEach(panel => {
        panel.addEventListener('mouseenter', cancelClose);
        panel.addEventListener('mouseleave', scheduleClose);
      });

      document.addEventListener('click', (e) => {
        if (!e.target.closest('[data-mega]') && !e.target.closest('.mega-panel')) {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });

      document.addEventListener('keydown', (e) => {
        if (e.key === 'Escape') {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });
    })();

    // Mobile menu
    const mobileMenuBtn = document.getElementById('mobile-menu-btn');
    const mobileMenu = document.getElementById('mobile-menu');
    const menuIcon = document.getElementById('menu-icon');
    const closeIcon = document.getElementById('close-icon');
    if (mobileMenuBtn) {
      mobileMenuBtn.addEventListener('click', () => {
        mobileMenu.classList.toggle('hidden');
        menuIcon.classList.toggle('hidden');
        closeIcon.classList.toggle('hidden');
      });
    }

    // Mobile accordion sections
    document.querySelectorAll('.mobile-section-toggle').forEach(btn => {
      btn.addEventListener('click', () => {
        const section = btn.nextElementSibling;
        const chevron = btn.querySelector('svg');
        section.classList.toggle('hidden');
        chevron.style.transform = section.classList.contains('hidden') ? '' : 'rotate(180deg)';
      });
    });
  </script>
</body>
</html>